Vahaticor, Inc.
Clinical trials sponsored by Vahaticor, Inc., explained in plain language.
-
Tiny implant aims to relieve chest pain when Heart's small vessels fail
Disease control Recruiting nowThis early study tests a device called the A-FLUX Reducer, which is implanted into a vein in the heart to help blood flow. It is for people with chest pain caused by problems in the heart's tiny blood vessels (microvascular dysfunction). The study will enroll 30 adults and focus …
Phase: NA • Sponsor: VahatiCor, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New heart device aims to quiet chest pain in Hard-to-Treat condition
Symptom relief Recruiting nowThis study tests a new device called the A-FLUX Coronary Sinus Reducer to see if it can safely improve chest pain or discomfort in people with coronary microvascular dysfunction (CMD), a condition where tiny heart vessels don't work properly. About 30 adults with persistent sympt…
Phase: NA • Sponsor: VahatiCor, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC